Neoprobe, Damon Pharm Ltd. deal

Damon (Seoul) received exclusive marketing and distribution rights on the Korean peninsula to NEOP's RIGS products, which include targeting agents and gamma-detecting instruments for surgical detection and treatment of cancer.

Damon will conduct RIGScan trials and submit regulatory applications for marketing approval in Korea. NEOP will supply RIGS products at agreed upon transfer prices and will receive additional royalties. ...